| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 06/15/2005 | EP1539729A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 06/15/2005 | EP1539696A2 Process for preparing quinolin antibiotic intermediates |
| 06/15/2005 | EP1539695A1 N-4-piperidinyl compounds as ccr5 modulators |
| 06/15/2005 | EP1539693A1 Cannabinoid receptor agonists |
| 06/15/2005 | EP1539683A2 Phenol derivatives and their use as rotamase inhibitors |
| 06/15/2005 | EP1539679A2 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
| 06/15/2005 | EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 06/15/2005 | EP1539674A1 Amino-propanol derivatives |
| 06/15/2005 | EP1539662A1 Cannabinoid receptor ligands |
| 06/15/2005 | EP1539222A1 Treatment for eye disorder |
| 06/15/2005 | EP1539198A2 Lentiviral vector-mediated gene transfer and uses thereof |
| 06/15/2005 | EP1539196A1 Vitreoretinal tamponades based on fluorosilicone fluids |
| 06/15/2005 | EP1539182A1 Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |
| 06/15/2005 | EP1539179A2 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
| 06/15/2005 | EP1539174A2 Use of pde iv inhibitors to treat angiogenesis |
| 06/15/2005 | EP1539157A2 Method of inhibiting choroidal neovascularization |
| 06/15/2005 | EP1539137A1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 06/15/2005 | EP1539131A2 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 06/15/2005 | EP1538913A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 06/15/2005 | EP1538888A2 Upper hitch link |
| 06/15/2005 | EP1345609B1 Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists |
| 06/15/2005 | EP1326866B1 Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines |
| 06/15/2005 | EP1325007B1 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 06/15/2005 | EP1311259B1 Pharmaceutical composition comprising an ester of 5-aminolevulinic acid as photochemotherapeutic agent and a mucoadhesive agent |
| 06/15/2005 | EP1289916A4 Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls |
| 06/15/2005 | EP1276496B1 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 06/15/2005 | EP1104412B1 Tace inhibitors |
| 06/15/2005 | CN1628116A Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 06/15/2005 | CN1628113A Substituted indoles as alpha-1 agonists |
| 06/15/2005 | CN1628109A Novel aryl- and heteroarylpiperazines |
| 06/15/2005 | CN1628104A Quinazolinone derivatives and their use as CB agonists |
| 06/15/2005 | CN1628103A Pyrimidine derivitive |
| 06/15/2005 | CN1628101A 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6 |
| 06/15/2005 | CN1627970A Safety shield system for prefilled syringe |
| 06/15/2005 | CN1626552A Angiogenesis related molecules |
| 06/15/2005 | CN1626516A Novel intermediate for prepn. of pyrazolopyrimidinones |
| 06/15/2005 | CN1626207A Preparation including unique ingredient and fabricating method |
| 06/15/2005 | CN1626204A 'Jinqukang' oral liquid |
| 06/15/2005 | CN1626203A 'Yanxieting' oral liquid |
| 06/15/2005 | CN1626202A 'Yishiming' oral liquid |
| 06/15/2005 | CN1626199A Powder injection preparation for generating channels and vessels, and preparation method |
| 06/15/2005 | CN1626079A Fibrauretine injection preparation and preparing method |
| 06/15/2005 | CN1626077A Treatment of nuerodegenerative diseases |
| 06/15/2005 | CN1626069A Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy |
| 06/15/2005 | CN1206242C Anti-angiogenesis and anti-cancer function of angiogenin combined with nucleotide |
| 06/15/2005 | CN1206219C N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 06/15/2005 | CN1205980C Medicine for treating eye disease |
| 06/15/2005 | CN1205942C Archimycin gel for eye application |
| 06/15/2005 | CN1205938C Products having function of improving microcirculation action of mammal |
| 06/15/2005 | CN1205932C Method of using (2-imidazolin-2-ylamino) quinoxalines in treating neural injury |
| 06/14/2005 | US6906175 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor. |
| 06/14/2005 | US6906174 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 06/14/2005 | US6906170 Anti-inflammatory peptides derived from IL-2 and analogues thereof |
| 06/14/2005 | US6906097 A 7-(5-oxo-pyrrolidin-1-yl)-heptanoic acid or ester derivatives for therapeutic treatment of eye hypertension or glaucoma |
| 06/14/2005 | US6906092 Method of inhibiting matrix metalloproteinases |
| 06/14/2005 | US6906089 Kidney disease; cardiovascular disorders; antiscarring agents; wound healing agents |
| 06/14/2005 | US6906073 Piperazine CCR-3 receptor antagonists |
| 06/14/2005 | US6906065 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
| 06/14/2005 | US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents |
| 06/14/2005 | US6906051 Viricides, fungicides, microbiocides, osteoporosis |
| 06/14/2005 | US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases |
| 06/14/2005 | CA2400318C Botulinum toxin pharmaceutical compositions |
| 06/09/2005 | WO2005051912A1 Piperidine compound and method for producing same |
| 06/09/2005 | US20050124691 Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same |
| 06/09/2005 | US20050124680 Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment |
| 06/09/2005 | US20050124642 (1-Indanone)-(1,2,3,6-tetrahydropyridine) compounds |
| 06/09/2005 | US20050124631 For example, 2-amino-7-chloro-6-hydroxy-4-methylbenzothiazole; compounds that prevent the formation of polyglutamine containing protein aggregates; treatment of spinal and bulbar muscular atrophy, dentatorubal pallidoluysian atrophy, spinocerebellar ataxia, Alzheimers disease |
| 06/09/2005 | US20050124621 Novel inhibitors of kinases |
| 06/09/2005 | US20050124605 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating circulatory, inflammatory, and proliferative disorders |
| 06/09/2005 | US20050124594 Prophylactic treatment of eyes as having high risk of developing choroidal neovascularisation in macular degerneration by injecting an antiinflammatory steroid, e.g., triamcinolone acetonide, into the vitreous; occult and classic neovascularisation; mixture with antibiotic or angiogenesis inhibitors |
| 06/09/2005 | US20050124577 8-Azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| 06/09/2005 | US20050124574 Purine derivatives |
| 06/09/2005 | US20050124561 Administering fungicide for mucous membrane; asthma therapy |
| 06/09/2005 | US20050124036 Method for producing recombinant proteins in micro-organisms |
| 06/09/2005 | US20050123999 Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods |
| 06/09/2005 | US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders |
| 06/09/2005 | US20050123897 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area; drug delivery kits, patches |
| 06/09/2005 | US20050123605 Anticancer agents; prevent forming blood vessels; removal blockage |
| 06/09/2005 | US20050123576 Mupirocin compositions for topical use, an improved process of making same and methods of using same |
| 06/09/2005 | US20050123575 Heating, cooling, reheating and recooling a mixture containing hard fat while stirring; cosmetics, cosmeceutical, pharmaceutical; second temperature is lower than the congelation temperature of the mixture; hard fat is a mixture of triester of glycerin with caprylic, capric and stearic acids |
| 06/09/2005 | US20050123568 Chromatographic purification steps using unbuffered aqueous bases as eluent and subsequent neutralization; low side effect for specific immunotherapy of this pollen allergy; reduced immunoglobulin E binding with simultaneous retention of therapeutically relevant T-cell stimulation |
| 06/09/2005 | US20050123558 Modifeid polypeptide |
| 06/09/2005 | US20050123536 Treatment of immunological disorders using anti-dc30 antibodies |
| 06/09/2005 | US20050123512 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis |
| 06/09/2005 | CA2547467A1 Piperidine compound and method for producing same |
| 06/08/2005 | EP1537870A2 Methods and compositions for treating cancer |
| 06/08/2005 | EP1537857A1 Mupirocin compositions for topical use, a process of making same and uses thereof |
| 06/08/2005 | EP1537112A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 06/08/2005 | EP1537096A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 06/08/2005 | EP1537086A2 Novel phenanthridines |
| 06/08/2005 | EP1537084A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
| 06/08/2005 | EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers |
| 06/08/2005 | EP1537069A2 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE |
| 06/08/2005 | EP1536819A2 Use of rom production and release inhibitors to treat and prevent intraocular damage |
| 06/08/2005 | EP1536797A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough |
| 06/08/2005 | EP1536793A1 Pharmaceutical compositions comprising fk506 derivatives and the ir use for the treatment of allergic diseases |
| 06/08/2005 | EP1465854A4 Chalcone derivatives and their use to treat diseases |
| 06/08/2005 | EP1458706A4 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 06/08/2005 | EP1373231B1 3-heterocyclyl-propano-hydroxamic acid as pcp inhibitors |
| 06/08/2005 | EP1339418A4 Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |